Collegium Pharmaceutical Inc (COLL)

Working capital turnover

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Revenue US$ in thousands 631,449 566,767 463,933 276,868 310,016
Total current assets US$ in thousands 482,257 537,600 419,989 315,543 277,888
Total current liabilities US$ in thousands 509,510 457,915 270,114 230,399 191,226
Working capital turnover — 7.11 3.10 3.25 3.58

December 31, 2024 calculation

Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $631,449K ÷ ($482,257K – $509,510K)
= —

Collegium Pharmaceutical Inc's working capital turnover has shown a decreasing trend over the years. In 2020, the company had a working capital turnover of 3.58, which decreased to 3.25 in 2021 and further declined to 3.10 in 2022. However, there was a significant improvement in 2023, with the ratio increasing to 7.11, indicating a more efficient utilization of working capital during that year. Unfortunately, the data is not available for 2024, which limits our ability to provide a complete analysis for that year. Overall, Collegium Pharmaceutical Inc's working capital turnover demonstrates fluctuations, suggesting varying levels of efficiency in managing its working capital over the years.